Bond J F, Garman R D, Keating K M, Briner T J, Rafnar T, Klapper D G, Rogers B L
ImmuLogic Pharmaceutical Corporation, Cambridge, MA 02139.
J Immunol. 1991 May 15;146(10):3380-5.
The relationship between the structure and abundance of an inhaled protein and its potential for causing an allergic response is unknown. This study analyzes Amb a I, a family of related proteins formerly known as Ag E, that comprise the major allergens of short ragweed (Ambrosia artemisiifolia). T cells isolated from ragweed allergic patients were shown to proliferate in response to purified Amb a I.1 protein from pollen in in vitro secondary cultures, demonstrating the presence of T cell stimulatory epitopes in Amb a I.1. Three recombinant forms of Amb a I (Amb a I.1, Amb a I.2, and Amb a I.3) obtained as cDNA derived from pollen mRNA were expressed in bacteria. All three recombinant forms were shown to be specifically recognized by pooled ragweed-allergic human IgE on immunoblots, confirming these gene products are important allergens. An examination of immunoblots probed with sera derived from allergic patients revealed a variation in IgE binding specificity. A minority of patients' IgE exclusively reacted with recombinant Amb a I.1, whereas most patients' IgE reacted with Amb a I.1 as well as Amb a I.2 and Amb a I.3 proteins. A detailed examination of the reactivity of T cells derived from 12 allergic patients to these recombinant Amb a I forms revealed that these allergens are all capable of stimulating T cell proliferation in in vitro assays. It is concluded that the allergic response to ragweed pollen in most allergic patients is composed of a reaction to multiple related Amb a I proteins at both the B and T cell levels.
吸入性蛋白质的结构与丰度与其引发过敏反应的可能性之间的关系尚不清楚。本研究分析了Amb a I,这是一族以前称为Ag E的相关蛋白质,它们构成了短豚草(Ambrosia artemisiifolia)的主要过敏原。从豚草过敏患者中分离出的T细胞在体外二次培养中对来自花粉的纯化Amb a I.1蛋白有增殖反应,证明Amb a I.1中存在T细胞刺激表位。通过从花粉mRNA获得的cDNA得到的三种重组形式的Amb a I(Amb a I.1、Amb a I.2和Amb a I.3)在细菌中表达。在免疫印迹上,所有三种重组形式都被豚草过敏患者的混合人IgE特异性识别,证实这些基因产物是重要的过敏原。用过敏患者血清检测免疫印迹发现IgE结合特异性存在差异。少数患者的IgE仅与重组Amb a I.1反应,而大多数患者的IgE与Amb a I.1以及Amb a I.2和Amb a I.3蛋白都有反应。对12名过敏患者来源的T细胞对这些重组Amb a I形式的反应性进行详细检测发现,这些过敏原在体外试验中都能够刺激T细胞增殖。得出的结论是,大多数过敏患者对豚草花粉的过敏反应在B细胞和T细胞水平上都是由对多种相关Amb a I蛋白的反应组成的。